Evolent Health, Inc. (EVH) stock
EVHNYSEServices-Management ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3055% below fair value
$3.93−0.69 (-14.94%)
Close on Nov 18, 2026Market cap $444.32MP/E –Yield –
Evolent Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Evolent Health's revenue for the twelve months ending Jun 30, 2026 was $2.10B, down 4.5% year over year. For fiscal 2025 it was $1.88B, down 26.6% from the year before. Over ten years it grew 34.5% a year on average. The highest annual figure on record is $2.55B in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88B | -26.6% |
| FY2024 | Dec 31, 2024 | $2.55B | +30.1% |
| FY2023 | Dec 31, 2023 | $1.96B | +45.3% |
| FY2022 | Dec 31, 2022 | $1.35B | +48.9% |
| FY2021 | Dec 31, 2021 | $907.96M | -1.8% |
| FY2020 | Dec 31, 2020 | $924.64M | +34.6% |
| FY2019 | Dec 31, 2019 | $687.12M | +9.6% |
| FY2018 | Dec 31, 2018 | $627.06M | +44.2% |
| FY2017 | Dec 31, 2017 | $434.95M | +71.1% |
| FY2016 | Dec 31, 2016 | $254.19M | +162.4% |
| FY2015 | Dec 31, 2015 | $96.88M | – |
| FY2014 | Dec 31, 2014 | $0 | -100.0% |
| FY2013 | Dec 31, 2013 | $25.67M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $652.52M | +46.9% |
| Q1 FY2026 | Mar 31, 2026 | $496.25M | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $468.72M | -27.5% |
| Q3 FY2025 | Sep 30, 2025 | $479.53M | -22.8% |
| Q2 FY2025 | Jun 30, 2025 | $444.33M | -31.3% |
| Q1 FY2025 | Mar 31, 2025 | $483.65M | -24.4% |
| Q4 FY2024 | Dec 31, 2024 | $646.54M | +16.3% |
| Q3 FY2024 | Sep 30, 2024 | $621.40M | +21.6% |
| Q2 FY2024 | Jun 30, 2024 | $647.15M | +37.9% |
| Q1 FY2024 | Mar 31, 2024 | $639.65M | +49.6% |
| Q4 FY2023 | Dec 31, 2023 | $556.06M | +45.4% |
| Q3 FY2023 | Sep 30, 2023 | $511.02M | +44.9% |
| Q2 FY2023 | Jun 30, 2023 | $469.14M | +46.6% |
| Q1 FY2023 | Mar 31, 2023 | $427.69M | +44.0% |
| Q4 FY2022 | Dec 31, 2022 | $382.43M | +54.0% |
| Q3 FY2022 | Sep 30, 2022 | $352.59M | +58.5% |
| Q2 FY2022 | Jun 30, 2022 | $319.94M | +44.1% |
| Q1 FY2022 | Mar 31, 2022 | $297.06M | +38.1% |
| Q4 FY2021 | Dec 31, 2021 | $248.36M | +0.7% |
| Q3 FY2021 | Sep 30, 2021 | $222.47M | -7.1% |
| Q2 FY2021 | Jun 30, 2021 | $222.06M | +2.2% |
| Q1 FY2021 | Mar 31, 2021 | $215.07M | -2.8% |
| Q4 FY2020 | Dec 31, 2020 | $246.54M | +4.2% |
| Q3 FY2020 | Sep 30, 2020 | $239.57M | +8.8% |
| Q2 FY2020 | Jun 30, 2020 | $217.30M | +13.2% |
| Q1 FY2020 | Mar 31, 2020 | $221.23M | +11.9% |
| Q4 FY2019 | Dec 31, 2019 | $236.53M | +22.5% |
| Q3 FY2019 | Sep 30, 2019 | $220.14M | +46.8% |
| Q2 FY2019 | Jun 30, 2019 | $191.96M | +33.0% |
| Q1 FY2019 | Mar 31, 2019 | $197.76M | +41.5% |
| Q4 FY2018 | Dec 31, 2018 | $193.10M | +69.8% |
| Q3 FY2018 | Sep 30, 2018 | $149.95M | +39.0% |
| Q2 FY2018 | Jun 30, 2018 | $144.30M | +34.8% |
| Q1 FY2018 | Mar 31, 2018 | $139.71M | +31.5% |
| Q4 FY2017 | Dec 31, 2017 | $113.73M | +29.2% |
| Q3 FY2017 | Sep 30, 2017 | $107.91M | +79.2% |
| Q2 FY2017 | Jun 30, 2017 | $107.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $106.24M | – |
| Q4 FY2016 | Dec 31, 2016 | $88.01M | – |
| Q3 FY2016 | Sep 30, 2016 | $60.21M | – |
See a number that looks wrong?